Lv11
10 积分 2024-12-11 加入
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
3小时前
待确认
A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan
5小时前
已完结
Drug-Coated Balloons for Coronary Artery Disease
26天前
已完结
Angiographic characteristics and long‐term outcomes of single‐vessel chronic total occlusion percutaneous coronary intervention in patients with and without previous myocardial infarction
1个月前
已完结
Intravascular ultrasound and ultrasonic flow ratio-guided zero-contrast percutaneous coronary intervention: first report of a novel technique treating a patient with obstructive coronary artery disease and contrast allergy
1个月前
已完结
Association between lipoprotein(a) and long-term outcomes after percutaneous coronary intervention for lesions with in-stent restenosis
1个月前
已完结
Comparison of Recurrent With First-Time In-Stent Restenosis
1个月前
已完结
The role of residual inflammatory risk and LDL cholesterol in patients with in-stent restenosis undergoing percutaneous coronary intervention
1个月前
已完结
5-Year Outcomes With a Novel Coronary Sirolimus-Eluting Bioresorbable Scaffold
1个月前
已完结
Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents
1个月前
已完结
皖公网安备34019202002308
